Gilead Sciences, Inc. (GILD) operating KPIs
GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)
Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%
Latest, FY2025
6.78
Period ended Dec 31, 2025
Change on a year earlier
+1,684.2%
0.38 in FY2024
History
19 years
Since FY2007
Sources
16
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Diluted earnings (loss) per share ($/sh) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6.78 | +1,684.2% | Form 10-K (filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 0.38 | -91.6% | Form 10-K (filed 2025-02-28) ↗ |
| FY2023 | Dec 31, 2023 | 4.50 | +23.6% | Form 10-K (filed 2024-02-23) ↗ |
| FY2022 | Dec 31, 2022 | 3.64 | -26.2% | Form 10-K (filed 2023-02-22) ↗ |
| FY2021 | Dec 31, 2021 | 4.93 | +4,830.0% | Form 10-K (filed 2022-02-23) ↗ |
| FY2020 | Dec 31, 2020 | 0.10 | -97.6% | Form 10-K (filed 2021-02-25) ↗ |
| FY2019 | Dec 31, 2019 | 4.22 | +1.2% | Form 10-K (filed 2020-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 4.17 | +18.8% | Form 10-K (filed 2019-02-26) ↗ |
| FY2017 | Dec 31, 2017 | 3.51 | -64.7% | Form 10-K (filed 2018-02-27) ↗ |
| FY2016 | Dec 31, 2016 | 9.94 | -16.5% | Form 10-K (filed 2017-02-27) ↗ |
| FY2015 | Dec 31, 2015 | 11.91 | +62.0% | Form 10-K (filed 2016-02-24) ↗ |
| FY2014 | Dec 31, 2014 | 7.35 | +306.1% | Form 10-K (filed 2015-02-25) ↗ |
| FY2013 | Dec 31, 2013 | 1.81 | +10.4% | Form 10-K (filed 2014-02-25) ↗ |
| FY2012 | Dec 31, 2012 | 1.64 | -7.3% | Form 10-K (filed 2013-02-27) ↗ |
| FY2011 | Dec 31, 2011 | 1.77 | +6.6% | Form 10-K (filed 2013-02-27) ↗ |
| FY2010 | Dec 31, 2010 | 1.66 | +17.7% | Form 10-K (filed 2011-02-28) ↗ |
| FY2009 | Dec 31, 2009 | 1.41 | +36.9% | Form 10-K (filed 2010-03-01) ↗ |
| FY2008 | Dec 31, 2008 | 1.03 | +25.6% | Form 10-K (filed 2010-03-01) ↗ |
| FY2007 | Dec 31, 2007 | 0.82 | – | Form 10-K (filed 2010-03-01) ↗ |
Cite this data
StockData. (2026). Gilead Sciences Diluted earnings (loss) per share ($/sh) ($), annual FY2007–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/fs_eps_dil
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.